STOCK TITAN
  1. Home
  2. Sec-filings
  3. GH
  4. [Form 4] Guardant Health, Inc. Insider Trading Activity

Guardant Health (GH) CLO exercises RSUs, 535 shares withheld for tax

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Guardant Health, Inc. Chief Legal Officer John G. Saia reported equity compensation activity on December 15, 2025. 1,020 Restricted Stock Units converted into common stock at $0 per share, and 535 common shares were withheld by the company to meet tax withholding obligations at $102.67 per share, as explained in a footnote. After these transactions he directly holds 43,657 shares of Guardant Health common stock.

Positive

  • None.

Negative

  • None.
Insider Saia John G.
Role Chief Legal Officer
Type Security Shares Price Value
Exercise Restricted Stock Units 1,020 $0.00 $0.00
Exercise Common Stock 1,020 $0.00 $0.00
Exercise Price or Tax Liability Common Stock 535 $102.67 $55K
Holdings After Transaction: Restricted Stock Units — 2,039 shares (Direct); Common Stock — 43,657 shares (Direct)
Footnotes (3)
  1. F1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
  2. F2. This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
  3. F3. Not applicable for Restricted Stock Units.
RSUs converted to common stock 1,020 shares Restricted Stock Units converted into Guardant Health common stock on 2025-12-15
Shares withheld for tax 535 shares Common shares retained by the company to meet tax withholding obligations at $102.67 per share
Tax withholding share price $102.67 per share Per-share value of Guardant Health common stock used for tax withholding on 535 shares
Post-transaction common stock holding 43,657 shares Guardant Health common stock held directly by John G. Saia after the reported transactions
RSU award grant date June 9, 2023 Grant date of the Restricted Stock Unit award described in the footnote
Initial RSU vesting tranche 33% of award First portion of the RSU award vested on June 15, 2024
Remaining RSU vesting 67% of award Remaining RSU shares vest in equal quarterly installments over two years
Restricted Stock Units financial
"This represents a restricted stock unit award granted on June 9, 2023"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"retained by the Company in order to meet the tax withholding obligations"
vests in equal quarterly installments financial
"the remaining 67% of the shares vests in equal quarterly installments"
exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What transactions did Guardant Health (GH) insider John G. Saia report?
John G. Saia reported the conversion of 1,020 Restricted Stock Units into Guardant Health common stock at $0 per share, and a tax-related withholding of 535 common shares at $102.67 per share on December 15, 2025, reflecting equity compensation activity.

How many Guardant Health (GH) shares does John G. Saia hold after these transactions?
Following the reported transactions, John G. Saia holds 43,657 shares of Guardant Health common stock directly. This post-transaction holding reflects his position after the RSU conversion and related tax-withholding share retention by the company.

What type of securities did John G. Saia convert in the Guardant Health (GH) filing?
John G. Saia converted 1,020 Restricted Stock Units into Guardant Health common stock on December 15, 2025, at a conversion price of $0 per share, reflecting the vesting and settlement of part of his equity compensation.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Saia John G.
(Last) (First) (Middle)
3100 HANOVER STREET
(Street)
PALO ALTO CA 94304
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/15/2025 M 1,020 A $0 44,192 D
Common Stock 12/15/2025 F 535(1) D $102.67 43,657 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0 12/15/2025 M 1,020 (2) (3) Common Stock 1,020 $0 2,039 D
Explanation of Responses:
1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
2. This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
3. Not applicable for Restricted Stock Units.
Remarks:
/s/ John G. Saia 12/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR